The Kymanox® device design and innovation team developed an electromechanical, reusable autoinjector as a platform device to be used by multiple pharmaceutical companies.


Kymanox needed to identify device requirements, generate intellectual property (IP), and develop a strategy for design and manufacturing of the device.


Kymanox consolidated and distilled device requirements from patients, providers, critical component manufacturers (i.e. glass and rubber), automation vendors, contract filling companies, and contract manufacturers. Kymanox created an industry-leading intellectual property portfolio which provided patients with an exceptional experience and built brand value for pharma partners.
Kymanox cultivated in-house expertise in both design and manufacture of the device in order to maintain control over development timelines and cost.


Kymanox generated IP and developed technologies for RFID/NFC syringe identification, Bluetooth connectivity, skin sensing, and pre-injection drug warming.